Salix Pharmaceuticals Ltd Watch

from SC TO-C 68 pages Project Sun Commitment Letter

from 8-K 73 pages License Agreement by and Among Cowen Healthcare Royalty Partners, L.P. and Shore Therapeutics, Inc. and Santarus, Inc. Dated December 21, 2011

from 8-K 14 pages You Have Informed Salix Pharmaceuticals, Inc. (“Salix” And, Collectively With Its Subsidiaries and Affiliates and Their Respective Successors and Assigns, the “Company”) of Your Decision to Retire From the Company Effective on the Earlier of (A) January 30, 2015 and (B) the Date on Which a Successor Chief Executive Officer of Salix (The “Successor CEO”) Is Appointed by the Board of Directors of Salix (The “Retirement Date”). the Company Desires Your Continued Support, Following the Retirement Date, in the Transition of Your Duties and Responsibilities and Certain Other Matters, and You Are Willing to Provide Such Support as a Consultant on the Terms and Subject to the Conditions Set Forth Below. This Letter Agreement (This “Agreement”) Sets Forth the Mutual Understandings and Agreements We Have Reached Regarding These Matters. Accordingly, in Reliance on the Promises Made in This Agreement, You, Salix and Salix Pharmaceuticals, Ltd. (“Parent”) Agree as of the Date Set Forth Above as Follows: 1. Continuation of Employment

from 8-K 12 pages Material contract

from 8-K 22 pages Dated 11 September 2014 Dr. Falk Pharma Gmbh - And - Salix Pharmaceuticals, Inc. First Amendment to License Agreement

from 8-K 25 pages Dated 11 September 2014 Dr. Falk Pharma Gmbh - And - Salix Pharmaceuticals, Inc. Second Amendment to License Agreement

from 8-K 4 pages Amendment Number Four to Supply Agreement

from 8-K 3 pages Amendment Number Three to Supply Agreement

from 8-K 8 pages Termination Agreement

from 8-K 10 pages Settlement Agreement

from 10-Q 91 pages Commercialization Agreement Article 1 Definitions

from 10-Q 2 pages Amendment No. 8 to Manufacturing and Supply Agreement

from 10-Q 35 pages Manufacturing and Supply Agreement

from 8-K 28 pages Salix Pharmaceuticals, Ltd. 2014 Stock Incentive Plan

from 8-K 16 pages Amended and Restated Employment Agreement

from 8-K 16 pages Amended and Restated Employment Agreement

from 8-K 16 pages Amended and Restated Employment Agreement

from 8-K 16 pages Amended and Restated Employment Agreement

from 10-K 47 pages License Agreement Preamble Article 1 Definitions

from 10-K 40 pages *** Certain Confidential Information Contained in This Document (Indicated by Asterisks) Has Been Omitted and Filed Separately With the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment Under 17 C.F.R. Sections 200.80(b)(4), 200.83 and 230.406. Exclusive License Agreement Between the University of Missouri and Santarus, Inc